• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米颗粒的药物递送和靶向系统的最新进展,重点是基于蛋白质的纳米颗粒。

Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles.

作者信息

Wang Guilin, Uludag Hasan

机构信息

Faculty of Engineering University of Alberta, Department of Chemical & Materials Engineering, #526 CME Building, Edmonton, Alberta, T6G2G6, Canada.

出版信息

Expert Opin Drug Deliv. 2008 May;5(5):499-515. doi: 10.1517/17425247.5.5.499.

DOI:10.1517/17425247.5.5.499
PMID:18491978
Abstract

BACKGROUND

Drug delivery systems with nm dimensions (nanoparticles [NPs]) are attracting increasing attention because they can sequester drugs in systemic circulation, prevent non-specific biodistribution, and target to specific tissues.

OBJECTIVE

We reviewed the recent literature pertinent to NP-based drug delivery, primarily emphasizing NPs fabricated from proteins.

METHODS

A summary of common NP fabrication techniques is provided along with the range of sizes and functional properties obtained. The NP properties critical for injectable drug delivery are reviewed, as well as the attempts to design 'tissue-specific' NPs.

RESULTS/CONCLUSIONS: It has been possible to design > 100 nm NPs from different biomaterials, and further understanding of in vivo stability and interactions with physiologic systems will lead to improved drug delivery systems.

摘要

背景

纳米尺寸的药物递送系统(纳米颗粒 [NPs])正吸引着越来越多的关注,因为它们可以在体循环中隔离药物,防止非特异性生物分布,并靶向特定组织。

目的

我们回顾了近期与基于纳米颗粒的药物递送相关的文献,主要侧重于由蛋白质制成的纳米颗粒。

方法

提供了常见纳米颗粒制备技术的总结以及所获得的尺寸范围和功能特性。综述了对可注射药物递送至关重要的纳米颗粒特性,以及设计“组织特异性”纳米颗粒的尝试。

结果/结论:已经能够用不同的生物材料设计出大于100纳米的纳米颗粒,对体内稳定性以及与生理系统相互作用的进一步了解将带来改进的药物递送系统。

相似文献

1
Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles.基于纳米颗粒的药物递送和靶向系统的最新进展,重点是基于蛋白质的纳米颗粒。
Expert Opin Drug Deliv. 2008 May;5(5):499-515. doi: 10.1517/17425247.5.5.499.
2
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.用于静脉注射的载多西他赛聚乳酸-羟基乙酸共聚物和聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒:药代动力学和生物分布特征
Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017.
3
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.用于体内靶向给药的功能化聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的制剂
Biomaterials. 2007 Feb;28(5):869-76. doi: 10.1016/j.biomaterials.2006.09.047. Epub 2006 Oct 20.
4
Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions.由纳米乳剂工程化的纳米粒子的胶凝含量对其稳定性、巨噬细胞相互作用和血液循环的影响。
Colloids Surf B Biointerfaces. 2012 Jun 1;94:259-65. doi: 10.1016/j.colsurfb.2012.02.005. Epub 2012 Feb 14.
5
Albumin corona on nanoparticles - a strategic approach in drug delivery.纳米粒子的白蛋白冠——药物递送的一种策略方法。
Drug Deliv. 2016 Oct;23(8):2668-2676. doi: 10.3109/10717544.2015.1048488. Epub 2015 Jun 9.
6
Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.药物递送中的纳米颗粒:作用机制、制剂以及降低药物相关性肾毒性的临床应用。
Expert Opin Drug Deliv. 2014 Oct;11(10):1661-80. doi: 10.1517/17425247.2014.938046. Epub 2014 Jul 23.
7
The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.纳米颗粒及载纳米颗粒微胶囊经口给药后在小鼠体内的命运:对其结肠特异性递送潜力的评估。
Eur J Pharm Biopharm. 2015 Aug;94:393-403. doi: 10.1016/j.ejpb.2015.06.014. Epub 2015 Jun 25.
8
Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.载双膦酸盐 BSA 纳米粒经全身给药后缺乏骨靶向性。
J Drug Target. 2010 Sep;18(8):611-26. doi: 10.3109/10611861003622560.
9
Fabrication of environmentally biodegradable lignin nanoparticles.制备环境可生物降解的木质素纳米粒子。
Chemphyschem. 2012 Dec 21;13(18):4235-43. doi: 10.1002/cphc.201200537. Epub 2012 Oct 9.
10
Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density.用于核靶向的壳聚糖纳米颗粒:纳米颗粒大小和核定位序列密度的影响
Mol Pharm. 2015 Dec 7;12(12):4277-89. doi: 10.1021/acs.molpharmaceut.5b00478. Epub 2015 Nov 10.

引用本文的文献

1
Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.用于靶向杀死癌细胞的纳米颗粒和基于细胞的药物递送系统的研究进展。
Oncol Res. 2024 Dec 20;33(1):27-44. doi: 10.32604/or.2024.056955. eCollection 2025.
2
From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration.从骨到纳米颗粒:新一代骨衍生纳米颗粒的开发用于影像引导的骨科再生。
Biomater Sci. 2024 Jul 9;12(14):3633-3648. doi: 10.1039/d4bm00391h.
3
Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs.
人血清白蛋白纳米颗粒:合成、优化及与抗结核药物的固定化
Polymers (Basel). 2023 Jun 22;15(13):2774. doi: 10.3390/polym15132774.
4
Nanomaterials for Protein Delivery in Anticancer Applications.用于抗癌应用中蛋白质递送的纳米材料。
Pharmaceutics. 2021 Jan 25;13(2):155. doi: 10.3390/pharmaceutics13020155.
5
Protein-Based Nanoparticles as Drug Delivery Systems.基于蛋白质的纳米颗粒作为药物递送系统
Pharmaceutics. 2020 Jun 29;12(7):604. doi: 10.3390/pharmaceutics12070604.
6
Antitumor Features of Vegetal Protein-Based Nanotherapeutics.基于植物蛋白的纳米治疗剂的抗肿瘤特性。
Pharmaceutics. 2020 Jan 15;12(1):65. doi: 10.3390/pharmaceutics12010065.
7
Nanoparticle-based bioactive agent release systems for bone and cartilage tissue engineering.用于骨和软骨组织工程的基于纳米颗粒的生物活性剂释放系统。
Regen Ther. 2015 Aug 7;1:109-118. doi: 10.1016/j.reth.2015.05.004. eCollection 2015 Jun.
8
Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma.使用微/纳米脂质溴丙酮酸壳聚糖载体抑制糖酵解作为改善肝细胞癌治疗的一种有前景的工具。
Nanomaterials (Basel). 2018 Jan 10;8(1):34. doi: 10.3390/nano8010034.
9
Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells.用于将 TGFβ 抑制剂靶向递送至肝癌细胞的杂化聚合物-蛋白纳米载体(HPPNC)。
J Mater Sci Mater Med. 2017 Aug;28(8):120. doi: 10.1007/s10856-017-5930-7. Epub 2017 Jul 6.
10
Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.基于植物蛋白的疏水性精细和超细载药系统载体颗粒。
Crit Rev Biotechnol. 2018 Feb;38(1):47-67. doi: 10.1080/07388551.2017.1312267. Epub 2017 Apr 24.